A new report reveals the heavy personal and economic toll of MS and recommends more complete, patient focused approaches to ...

Beginning Jan. 1, 2026, Optum Rx, the pharmacy benefit manager of UnitedHealthcare, will reduce reauthorizations for an ...

Kamuvudines are a new class of drugs that are derived from the anti-HIV nucleoside reverse transcriptase inhibitors. They are designed to inhibit the inflammasome, part of the innate immune system ...

It’s been discovered that a new tool using routine blood tests and a simple online app could help detect tuberculosis (TB) ...

ASTRO's new guidelines enhance radiation therapy strategies for gastric cancer, improving treatment outcomes and patient care ...

University of Pennsylvania researchers say their findings could potentially lead to the development of a blood test to monitor people at high risk of developing Type 1 diabetes. New research into ...

Telehealth replaces 74% of office visits, according to the operational analysis of telehealth utilization from 2019 to 2023, ...

Relmada Therapeutics is advancing NDV-01, a novel intravesical therapy for NMIBC, into phase 3 clinical trials, with Max ...

Ralph Abraham's appointment as CDC principal deputy director raises concerns due to his controversial vaccine stance and past actions as Louisiana's surgeon general. His appointment follows the forced ...

Each Sunday we feature a highlight reel of various articles posted on our website that week.

CMS has negotiated a 71% discount off the list price, or $274 for a 30-day supply, on Novo Nordisk’s semaglutide products — Ozempic and Rybelsus for diabetes and Wegovy for weight loss — through the ...

“Sarcopenia is prevalent among patients with ELD, with its prevalence varying across different populations due to multiple influencing factors, resulting in distinct clinical outcomes,” wrote lead ...